<?xml version="1.0" encoding="UTF-8"?>
<p id="Par61">In addition to the well-characterized activity of cathelicidins and defensins against a wide variety of viral pathogens, a number of CHDP from other non-human organisms have been the focus of a number of studies attempting to understand whether these peptides, or synthetic derivatives, could be used to inform the design of novel therapeutics against viral infections specific to humans.</p>
